" class="no-js "lang="en-US"> Alan Hirzel - Pharmtech Focus
Tuesday, January 31, 2023
Alan Hirzel

Alan Hirzel

About Alan Hirzel

As CEO of Abcam, my personal mission is to ensure that our team is working toward becoming the most influential life science company for researchers worldwide. That means we work on behalf of researchers and clinicians to help them advance their research missions faster than they might have otherwise. When they achieve that outcome, we all benefit.

It has been a privilege lead the transformation and change at Abcam. We are a unique innovation mash up of digital technology and proteomic and life sciences technologies.

As a company, we are friendly, dedicated to our mission, audacious in our goals, and agile in how we go after opportunities. Whether you are an customer, part of our team, or an investor, we hope you share our enthusiasm for our company and the future ahead of us. It is an exciting time to be alive and working in the life sciences.

Related Story

Abcam Completes $340m Strategic Acquisition and Expands Kit Capacity and Capability

October 27 2021

Abcam (AIM:ABC;NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion […]